Influence of menstrual cycle and oral contraceptives on tolerance to uncompensable heat stress.
In this study we examined the influence of menstrual cycle phase and oral contraceptive use on thermoregulation and tolerance during uncompensable heat stress. Eighteen women (18-35 years), who differed only with respect to oral contraceptive use (n = 9) or non-use (n = 9), performed light intermittent exercise at 40 degrees C and 30% relative humidity while wearing nuclear, biological and chemical protective clothing. Their responses were compared during the early follicular (EF, days 2-5) and mid-luteal (ML, days 19-22) phases of the menstrual cycle. Since oral contraceptives are presumed to inhibit ovulation, a quasi-early follicular (q-EF) and quasi-mid-luteal (q-ML) phase was assumed for the users. Estradiol and progesterone measurements verified that all subjects were tested during the desired phases of the menstrual cycle. Results demonstrated that rectal temperature (Tre) was elevated in ML compared with EF among the non-users at the beginning and throughout the heat-stress trial. For the users, Tre was higher in q-ML compared with q-EF at the beginning, and for 75 min of the heat-stress exposure. Tolerance times were significantly longer during EF [128.1 (13.4) min, mean (SD)] compared with ML [107.4 (8.6) min] for the nonusers, indicating that these women are at a thermoregulatory advantage during the EF phase of their menstrual cycle. For the users, tolerance times were similar in both the q-EF [113.0 (5.8) min] and q-ML [116.8 (11.2) min] phases and did not differ from those of the non-users. It was concluded that oral contraceptive use had little or no influence on tolerance to uncompensable heat stress, whereas tolerance was increased during EF for non-users of oral contraceptives.
Defence and Civil Institute of Environmental Medicine, Human Protection and Performance Section, North York, ON, Canada.
S A
SA
Tenaglia
T M
TM
McLellan
P P
PP
Klentrou
D000328:Adult; D001481:Basal Metabolism / Q000187:drug effects / Q000502:physiology; D001774:Blood Chemical Analysis; D001831:Body Temperature / Q000187:drug effects / Q000502:physiology; D001833:Body Temperature Regulation; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D015444:Exercise / Q000502:physiology; D005260:Female; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D018882:Heat Stress Disorders / Q000503:physiopathology*; D006801:Humans; D008183:Luteal Phase / Q000502:physiology; D008597:Menstrual Cycle / Q000378:metabolism / Q000502:physiology*; D011659:Pulmonary Gas Exchange / Q000187:drug effects / Q000502:physiology; D013546:Sweating / Q000187:drug effects / Q000502:physiology
D003278:Contraceptives, Oral, Hormonal